Clinical Trials Directory

Trials / Completed

CompletedNCT02821793

Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer

Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer : PRIORITY Study

Status
Completed
Phase
Study type
Observational
Enrollment
346 (actual)
Sponsor
Institut Bergonié · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective of study is to describe the priorities of elderly patients (70 years and over) undergoing a first medical treatment for cancer, at initiation of treatment and after 3 months of treatment. The main criterion is a prioritization of 4 items per patient from a list of 8 expectations regarding the objectives of their treatment: treatment efficacy, life expectancy, autonomy, daily activities, social activities, heaviness of treatment, toxicity, economics.

Detailed description

For the primary endpoint assessment, this self-administered patient questionnaire will used an opinion scale (Not at all, A little, Moderately, Enough, Many) to explore the eight domains. Next to the completion of the expectations questionnaire, patients will have to order 4 of the different 8 items that they prioritized in regard of the first line treatment that has just been prescribed by their physician. Secondary endpoint will focus on those 8 proposed expectations of patients at different periods of time since treatment initiation. Patients' priorities will be compared to physician's priorities (using the same prioritization grid) before medical treatment and after 3 months of treatment and to younger patients' priorities (18-69 years). Associations between elderly patients' characteristics (social, medical…) and their priorities will be search.

Conditions

Interventions

TypeNameDescription
OTHERConsultation, evaluation questionnaireConsultation, evaluation questionnaire
OTHERGeriatric consultation, evaluation questionnaireGeriatric consultation, evaluation questionnaire

Timeline

Start date
2016-01-01
Primary completion
2022-06-30
Completion
2023-12-31
First posted
2016-07-04
Last updated
2025-07-01
Results posted
2025-07-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02821793. Inclusion in this directory is not an endorsement.